# CatalYm

**Canonical:** https://apis.io/providers/catalym/  
**Website:** https://www.catalym.com/  
**APIs profiled:** 0

CatalYm GmbH is a clinical-stage biotechnology company based in Planegg-Martinsried near Munich, Germany, developing next-generation cancer immunotherapies. Its lead approach neutralizes GDF-15 (Growth Differentiation Factor 15) to reverse a key immune-resistance mechanism in solid tumors, aiming to reinstate anti-tumor immune activity and overcome resistance to checkpoint-inhibitor and other cancer therapies. The company is a portfolio company of Canaan Partners. This is a biotech/pharmaceutical organization with no public developer API, SDK, or documentation surface; it is tracked in the API Evangelist network as a company profile rather than an API provider.

## Kin Score — 6.1 / 100 (minimal)

Scored 2026-08-20 under rubric 0.12.0. Trend: flat (+0.0 from 6.1).

| Facet | Score |
|---|---|
| Discoverability | 50.0 |
| Contract Quality | 0.0 |
| Governance | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 0.0 |
| Commercial Clarity | 5.3 |
| Access Clarity | 5.3 |

## Agent readiness — 0.0 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |

## Access

Unknown — onboarding: unknown, pricing: unknown, trial: no (confidence: low).

## Tags

Company, Biotechnology, Pharmaceuticals, Immunotherapy, Oncology, Cancer, Drug Development, Germany

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/catalym/). Scores are computed from the provider's own public artifacts under a published rubric.